Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001021408-03-008971
Filing Date
2003-06-20
Accepted
2003-06-19 21:09:22
Documents
7
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FROM 10-K d10ka.htm 10-K/A 837305
3 RESTATED CONSULTING AGREEMENT dex1026.htm EX-10.26 23249
4 RESTATED CONSULTING AGREEMENT dex1027.htm EX-10.27 21153
5 RESTATED CONSULTING AGREEMENT dex1028.htm EX-10.28 22102
6 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1715
7 CERTIFICATION PURSUANT TO SECTION 302 dex991.htm EX-99.1 19982
8 CERTIFICATION PURSUANT TO SECTION 906 dex992.htm EX-99.2 4131
  Complete submission text file 0001021408-03-008971.txt   932028
Mailing Address 401 QUEEN ANNE AVE NORTH SEATTLE WA 98109
Business Address 4350 EXECUTIVE DRIVE,SUITE 325 SAN DIEGO CA 92121 2062989400
CYPRESS BIOSCIENCE INC (Filer) CIK: 0000716054 (see all company filings)

EIN.: 222389839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-12943 | Film No.: 03750835
SIC: 2836 Biological Products, (No Diagnostic Substances)